State coverage
Medicaid, for obesity: Does not cover. The conditions and the appeal deadline are in the summary below.
Georgia's answer is old, stable and easy to read, which makes it unusual. Its pharmacy manual carries the federal list of drug categories a state may leave out, and the first entry on that list is agents used for anorexia, weight loss or weight gain. Nothing recent changed it, so there is no bulletin here to cite and no reversal to explain.
The interesting part is the exception, because it is not the one you would predict. Georgia does cover two weight-related drugs, Xenical and Saxenda, and it covers them only for children and teenagers. Its own criteria say so in a single sentence: they are not covered for anyone under 12 or for anyone 18 or over. Saxenda is a GLP-1, so Georgia is a state where this class of drug is available for a weight-related reason at 17 and unavailable at 18.
Everything else in the class is gated on diabetes. We read Georgia's prior-authorization criteria for the antidiabetic agents and every approval pathway in it turns on a type 2 diabetes diagnosis; the words obesity and weight do not appear in that document at all. We also searched both versions of the state's preferred drug list effective August 1, 2026, by class and by drug name: Wegovy and Zepbound return no matches in either, while Ozempic and Saxenda each return one, so the search was working. The list says of itself that it does not include every drug the program covers, so read that as what the list shows rather than as a coverage decision.
One limit we will not paper over. We could not establish from any Georgia document that the managed care plans have to use the state's list. Every criteria document we opened is headed for fee-for-service, and the pharmacy manual tells providers to ask each plan about its own prior authorization requirements and prints three different plan pharmacy administrators. So treat what follows as the fee-for-service position and check your own plan's drug list. We are not telling you Georgia has a single statewide list, because we did not find a document saying it does.
Georgia's pharmacy manual names the exclusion. It says that "As provided by Section 1927(d)(2) of the Act, certain outpatient drugs may be excluded from coverage. Those excluded are:" and the first item under that is "Agents used for anorexia, weight loss or weight gain." This is a category, not a decision about any particular product.
Georgia Department of Community Health, Part II Policies and Procedures for Pharmacy Services, effective July 2026 · source · read August 2026
There is one door and it is age-limited. Georgia's criteria state: "NOTE: Xenical and Saxenda are not covered for members younger than 12 years of age or for members 18 years of age and older and requires prior authorization for members 12 to 17 years of age." For a teenager who qualifies, Saxenda is "Approvable for members 12 to 17 years of age with a diagnosis of hypercholesterolemia or hyperlipidemia who are currently taking lipid-lowering medications, who weigh greater than 60 kg and who have an initial body mass index (BMI) of 30 kg/m2 or greater," used "as an adjunct to a reduced-calorie diet and increased physical activity," and only after an inadequate response, allergy, contraindication or intolerable side effect with Xenical. Authorization runs one year. ⚠ This document prints one date, "Revised 07/09/2021," and it is the version the state's own criteria index links today.
Georgia Medicaid Fee-for-Service, Antihyperlipidemics Other Prior Authorization Summary, effective July 2021 · source · read August 2026
Every other GLP-1 in Georgia is a diabetes drug. The state's antidiabetic criteria approve Ozempic, for instance, "for members 18 years of age or older with a diagnosis of type 2 diabetes mellitus (T2DM) whose HbA1c level is 6.5% or higher when the requested medication is being used to improve glycemic control." We searched that document for the words obesity and weight and found neither anywhere in it, while type 2 diabetes mellitus appears throughout.
Georgia Medicaid Fee-for-Service, Antidiabetic Agents Prior Authorization Summary, effective July 2026 · source · read August 2026
We searched both versions of Georgia's preferred drug list effective August 1, 2026 — the one arranged by class and the one arranged by drug name. Wegovy and Zepbound return no matches in either. Ozempic and Saxenda each return one, which is how we know the search was working rather than silently failing. Mounjaro, Ozempic and Victoza are listed preferred with prior authorization and quantity limits under "MISC. ANTIDIABETIC AGENTS"; Saxenda is listed non-preferred with "PA (12 yrs-17 yrs)" and Xenical as "XENICAL (covered 12 - 17 yrs old)." The list adds its own warning, which is the reason we are phrasing this as what the list shows: "This list does not include all drugs covered under the Georgia Medicaid/PeachCare for Kids outpatient pharmacy program."
Georgia Department of Community Health, Georgia Medicaid and PeachCare Preferred Drug List, effective August 2026 · source · read August 2026
Georgia does publish one obesity pathway, and it is for a rare genetic condition rather than for obesity generally. Setmelanotide is "Approvable for members 2 to 17 years of age with a diagnosis of syndromic or monogenic obesity in the 95th percentile of the member's weight using growth chart assessments or members 18 years of age or older with a diagnosis of syndromic or monogenic obesity with a body mass index (BMI) of 30 kg/m2 or greater who have proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1) or leptin receptor (LEPR) deficiency," with a parallel route for Bardet-Biedl syndrome. It is listed non-preferred.
Georgia Medicaid Fee-for-Service, Imcivree Prior Authorization Summary, effective January 2026 · source · read August 2026
Georgia gives you 30 days and counts them from the letter, not from when it reached you. Its manual says: "A hearing must be requested either in writing or by email. The hearing request and a copy of the adverse action letter must be received by the Department within 30 days or less from the date of the adverse action letter." You can keep your medicine meanwhile — "Members may continue their services during the appeal if they submit a written request for continued services before the date that the services change." Two limits: the section says "This section does not apply to PeachCare for Kids members," and it does not say whether a Georgia Families plan appeal has to finish first, so ask your plan.
Georgia Department of Community Health, Part I Policies and Procedures for Medicaid and PeachCare for Kids, effective July 2026 · source · read August 2026
Medicaid is only one of the routes. If you have a commercial or employer plan, the rules are different and are on the employer plans page; Medicare has a federal rule of its own, on the Part D page.
If the appeal fails, or you cannot wait
Cash-pay telehealth is the fallback, not the bargain: you pay the whole cost yourself, and a covered prescription is almost always cheaper than any of these. Use this route when coverage has actually been exhausted, or when you need to start while an appeal runs.
These companies pay us a commission if you start care through the links below. That is how this site is funded, and it does not change what is written above. How we pay for this.
Prices in those notes were read from each company's own site in August 2026 and change often. Check the current number before you buy.
Every state we have verified is in the coverage matrix. Appeal routes and deadlines are on the procedures page.